Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.
“We are uniquely integrating data, science and the lived experiences from the patients that we serve into all ongoing product development efforts related to our flagship breast cancer program. Our objective is to detect earlier, diagnose easier and treat more comprehensively for the nearly 100M women who are currently underserved by existing standards of care.” Mammogen CEO, Elizabeth Cormier-May
Highlights
Women’s health startup Mammogen annoucnes a $2M seed round and the debut of its genTRU liquid biopsy platform.
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
